Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

NCT03558997 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: Dupilumab
DRUG: Timothy Grass SCIT
DRUG: Placebo matching dupilumab
DRUG: Placebo matching SCIT

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]